{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T08:39:13Z","timestamp":1768120753299,"version":"3.49.0"},"reference-count":111,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>Allergic reactions to endoprostheses are uncommon and reported in association with orthopaedic, dental, endovascular and other implanted devices. Hypersensitivity reactions to the biomaterials used in endovascular prostheses are among the infrequent reactions that may lead to local or systemic complications following cardiovascular therapeutic interventions. This article reviews potential immunotoxic effects of commonly used biomaterials. Reports of putative hypersensitivity reactions to endovascular devices, including coronary stents, perforated foramen occluders, pacemakers and implantable cardioverter defibrillators are also reviewed.<\/jats:p>","DOI":"10.1111\/j.1600-0536.2008.01351.x","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:50:15Z","timestamp":1212627015000},"page":"7-22","source":"Crossref","is-referenced-by-count":115,"title":["Hypersensitivity reactions associated with endovascular devices"],"prefix":"10.1111","volume":"59","author":[{"given":"Golara","family":"Honari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Wilkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars G.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_9_2_2","volume-title":"Biomaterials Science: An Introduction to Materials in Medicine","author":"Ratner B D","year":"2004"},{"key":"e_1_2_9_3_2","unstructured":"U.S. Department Of Health And Human Services Food and Drug Administration Center for Devices and Radiological Health Molecular Biology Branch Division of Life Sciences Office of Science and Technology.Guidance for Industry and FDA Reviewers \u2013 Immunotoxicity Testing Guidance Rockville FDA 1999. (available fromhttp:\/\/www.fda.gov\/cdrh\/ost\/ostggp\/immunotox.html) accessed on 16 June 2005."},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(03)00142-X"},{"key":"e_1_2_9_5_2","volume-title":"Immunology","author":"Roitt I","year":"2001"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1981.tb04063.x"},{"key":"e_1_2_9_7_2","first-page":"667","article-title":"Immediate type allergies due to metal \u2013 nickel","volume":"57","author":"Van Kampen V","year":"2003","journal-title":"Pneumologie"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-199905000-00003"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116202.41966.D4"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.07.071"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916931000148818"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sap.0000128087.51384.f9"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-005-0231-4"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.suppl_4.IV-81"},{"key":"e_1_2_9_15_2","first-page":"40S","article-title":"Pathobiology of restenosis after angioplasty","volume":"94","author":"Haudenschild C C","year":"1993","journal-title":"Am J Med"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16850-5"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000028335.31300.DA"},{"key":"e_1_2_9_18_2","unstructured":"MathewsR J.Cardiology; stent.2002. (available fromhttp:\/\/www.rjmatthewsmd.com\/) accessed on 23 May 2005."},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4636(199708)36:2<145::AID-JBM2>3.0.CO;2-K"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.1052"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1615\/JLongTermEffMedImplants.v15.i1.50"},{"key":"e_1_2_9_22_2","first-page":"191","article-title":"The contact allergens nickel chloride and cobalt chloride directly induce expression of endothelial adhesion molecules","volume":"92","author":"Goebeler M","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12476328"},{"key":"e_1_2_9_24_2","unstructured":"Medtronic Vascular.Advantages of Cobalt Alloy for Coronary Stents Minneapolis Medtronic 2003. (available fromhttp:\/\/www.medtronic.com\/newsroom\/content\/1110132739468.pdf) accessed on 20 February 2006."},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2004.04038"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04668.x"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155501750208155"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2005.04.004"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01119.x"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1690"},{"key":"e_1_2_9_31_2","unstructured":"Cordis Corporation.CYPHER\u2122 Sirolimus\u2010Eluting Coronary Stent on RAPTORTM Over\u2010the\u2010Wire Delivery System Miami Lakes Cordis Corporation 2003. (available fromhttp:\/\/www.fda.gov\/cdrh\/pdf3\/P020026c.pdf) accessed on 12 February 2006."},{"key":"e_1_2_9_32_2","unstructured":"Boston Scientific Corporation.Taxus \u2013 Paclitaxel\u2010Eluting Coronary Stent System. Natick Boston Scientific Corporation 2003. (available fromhttp:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/4005b1_03_Labeling.pdf) accessed on 12 February 2006."},{"key":"e_1_2_9_33_2","unstructured":"Boston Scientific Corporation.Directions for use. Natick Boston Scientific Corporation 2004. (available fromhttp:\/\/www.taxus\u2010stent.com\/usa\/dfu.html?ClickType=rn\u2010dfu) accessed on 12 February 2006."},{"key":"e_1_2_9_34_2","volume-title":"Medtronic\u2018s Sterilization Process. CRM Technical Service Standard Letter","author":"Medtronic"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.7.1461"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.0654e.x"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00598.x"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1987.tb02638.x"},{"key":"e_1_2_9_39_2","first-page":"189","article-title":"Dermatologic hazards from ethylene oxide","volume":"19","author":"Taylor J S","year":"1977","journal-title":"Cutis"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(78)90069-6"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03262-1"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.470607.x"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00522.x"},{"key":"e_1_2_9_44_2","first-page":"9","article-title":"Gold concentration in blood in patients treated with intracoronary stents","volume":"55","author":"Ekqvist S","year":"2006","journal-title":"Contact Dermatitis"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.206.243"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.12.034"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04350-6"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00719.x"},{"key":"e_1_2_9_49_2","unstructured":"AlongeL KroenM.Information for Physicians on Sub\u2010Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER\u2122 Coronary Stent Rockville FDA 2003. (available fromhttp:\/\/www.fda.gov\/cdrh\/safety\/cypher.html) accessed on 12 February 2006."},{"key":"e_1_2_9_50_2","unstructured":"AlongeL KroenM.Updated Information for Physicians on Sub\u2010Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER\u2122 Sirolimus\u2010Eluting Coronary Stent Rockville FDA 2003. (available fromhttp:\/\/www.fda.gov\/cdrh\/safety\/cypher2.html) accessed on 12 February 2006."},{"key":"e_1_2_9_51_2","unstructured":"AlongeL.Final Update of Information for Physicians on Sub\u2010Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER\u2122 Sirolimus\u2010eluting Coronary Stent Rockville FDA 2004. (available fromhttp:\/\/www.fda.gov\/cdrh\/safety\/cypher3.html) accessed on 20 January 2006."},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2131"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127439.49959.64"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)40065-2"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00650-X"},{"key":"e_1_2_9_56_2","unstructured":"FDA Document \u2013 Amplatzer. Summary of Safety and Probable Benefit.2000. (available fromhttp:\/\/www.fda.gov\/cdrh\/pdf\/h000007b.pdf) accessed on 12 February 2006."},{"key":"e_1_2_9_57_2","volume-title":"FDA Document. CardioSEAL\u00d2 Septal Occlusion System with Qwik Load\u00d4 Summary of Safety and Effectiveness Data","year":"2001"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.7"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2003.125"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2003.06.005"},{"key":"e_1_2_9_61_2","first-page":"681","article-title":"Nickel allergy and the amplatzer septal occluder","volume":"16","author":"Singh H R","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_9_62_2","unstructured":"Medtronic.History of Pacemakers: Technology Development Through the Decades. Minneapolis Medtronic. (available fromhttp:\/\/www.medtronic.com\/brady\/patient\/pacemaker_history.html) accessed on 12 April 2006."},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80186-8"},{"key":"e_1_2_9_64_2","unstructured":"Medcompare.Implantable Cardiac EP Devices. (available fromhttp:\/\/www.medcompare.com\/jump\/529\/Implantable\u2010Cardiac\u2010EP\u2010Devices.html) accessed on 12 April 2006."},{"key":"e_1_2_9_65_2","first-page":"436","article-title":"Do implanted pacemaker leads and ICD leads cause metal\u2010related artifact in cardiac PET\/CT?","volume":"46","author":"DiFilippo F P","year":"2005","journal-title":"J Nucl Med"},{"key":"e_1_2_9_66_2","unstructured":"St. Jude Medical.Pacemakers St. Paul St. Jude Medical. (available fromhttp:\/\/www.sjm.com\/resources\/learnmoreabout.aspx?section=CardiacPacemakerSystem) accessed on 12 April 2006."},{"key":"e_1_2_9_67_2","first-page":"289","article-title":"Advances in the technology of pacing","volume":"18","author":"Dionisio P","year":"1999","journal-title":"Rev Port Cardiol"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1989.tb04759.x"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1992.tb00867.x"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1997.tb06188.x"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019518005809"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069721"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1979.04010010065021"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1983.tb04325.x"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1980.tb05601.x"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)90228-3"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2006.00535.x"},{"key":"e_1_2_9_78_2","first-page":"335","article-title":"Pacemaker contact dermatitis treated by wrapping with a polytetrafluoroethylene (PTFE) sheet","volume":"8","author":"Hiranaka T","year":"1992","journal-title":"Pacing Clin Electrophysiol"},{"key":"e_1_2_9_79_2","first-page":"403","article-title":"Pacemaker contact dermatitis treated with polytetrafluoroethylene sheet","volume":"16","author":"Kono K","year":"2000","journal-title":"J Arrhythmia"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.58.200"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2002.t01-1-00863.x"},{"key":"e_1_2_9_82_2","first-page":"41","article-title":"Allergic contact dermatitis to titanium in a pacemaker","volume":"55","author":"Freeman S","year":"2006","journal-title":"Contact Dermatitis"},{"key":"e_1_2_9_83_2","first-page":"37","article-title":"Telangiectatic erythematous cutaneous reaction to an implantable cardioverter defibrillator","volume":"14","author":"Ferringer T","year":"2003","journal-title":"Am J Contact Dermat"},{"key":"e_1_2_9_84_2","first-page":"340","article-title":"Circumscribed erythema after cardiac pacemaker implantation","volume":"83","author":"Maushagen E","year":"1994","journal-title":"Z Kardiol"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30549-7"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00011"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.00268.x"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)93174-2"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92763-0"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2000.043001035.x"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200103000-00017"},{"key":"e_1_2_9_92_2","first-page":"62","article-title":"Implantation of orthopaedic devices in patients with metal allergy","volume":"69","author":"Carlsson A","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_9_93_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2000.8587"},{"key":"e_1_2_9_94_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archderm.1981.01650090036021","article-title":"Cutaneous complications of orthopedic implants. A two\u2010year prospective study","volume":"117","author":"Kubba R","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_95_2","unstructured":"PoncinP MilletC ChevyJ ProftJ L.Comparing and Optimizing Co\u2010Cr Tubing for Stent Applications. Proceedings from the Materials & Processes for Medical Devices Conference \u20102527 Aug 2004 St. Paul MN USA.The Materials Information Society. (available fromwww.minitubes.com\/images\/brochure\/asm04.pdf) accessed on 20 February 2005."},{"key":"e_1_2_9_96_2","unstructured":"MarkN FrakeP KazanjianM YuL.Organ Replacement Web Page Final Project 2004 Providence Brown University 2004. (available fromhttp:\/\/biomed.brown.edu\/Courses\/BI108\/BI108_2004_Groups\/Group05\/Drug%20Eluting%20Stents\/products_and_clinical_trials.htm) BI108 2004. accessed on 20 December 2006."},{"key":"e_1_2_9_97_2","unstructured":"Cordis Corporation.Cypher\u00aeSirolimus\u2010Eluting Coronary Stent Miami Lakes Cordis Corporation 2005. (available fromhttp:\/\/www.jnj.com\/innovations\/new_features\/cypher_stent.htm;jsessionid=C4IHQ41Z2IRG4CQPCAOWU3YKB) accessed on 15 May 2007."},{"key":"e_1_2_9_98_2","unstructured":"European Medicines Agency.Pre\u2010authorisation evaluation of medicines for human.2006. (available fromhttp:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/5647706en.pdf.) accessed on 30 July 2007."},{"key":"e_1_2_9_99_2","unstructured":"Boston Scientific Corporation.TAXUS\u00aeExpress2\u2122 Paclitaxel\u2010Eluting Coronary Stent System Natick Boston Scientific Corporation 2007. (available fromhttp:\/\/www.bostonscientific.com\/med_specialty\/deviceDetail.jsp?task=tskBasicDevice.jsp&sectionId=4&relId=2 74 75 76&deviceId=11013) accessed on 15 May 2007."},{"key":"e_1_2_9_100_2","unstructured":"RileyK.FDA Approves Drug\u2010Eluting Stent for Clogged Heart Arteries.2008. (available from:http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2008\/NEW01787.html) accessed on 15 May 2007."},{"key":"e_1_2_9_101_2","doi-asserted-by":"crossref","unstructured":"BeijkM A PiekJ J.XIENCE V everolimus\u2010eluting coronary stent system: A novel second generation drug\u2010eluting stent.Expert Rev Med Devices2007:4:11\u201321.","DOI":"10.1586\/17434440.4.1.11"},{"key":"e_1_2_9_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20497"},{"key":"e_1_2_9_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1984.tb00986.x"},{"key":"e_1_2_9_104_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb02089.x"},{"key":"e_1_2_9_105_2","first-page":"52","article-title":"Pacemaker dermatitis from titanium","volume":"42","author":"Yamauchi R","year":"2000","journal-title":"Contact Dermatitis"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1159\/000251434"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1980.tb05593.x"},{"key":"e_1_2_9_108_2","first-page":"253","article-title":"Contact dermatitis following cardiac pacemaker implantation","volume":"89","author":"Moini C","year":"1996","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1981.tb04094.x"},{"key":"e_1_2_9_110_2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archderm.1970.04000120064011","article-title":"Dermatitis associated with an implanted cardiac pacemaker","volume":"102","author":"Raque C","year":"1970","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1985.tb01089.x"},{"key":"e_1_2_9_112_2","first-page":"117","article-title":"Dermites au pacemaker","volume":"8","author":"Gimenez C J","year":"1985","journal-title":"Acta Dermatol"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0536.2008.01351.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0536.2008.01351.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T15:16:13Z","timestamp":1697469373000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0536.2008.01351.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1600-0536.2008.01351.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0536.2008.01351.x","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}